Beskrivelse
JACOBSON, Matthew P., 370 Arkansas Street, San Francisco, California 94107,
US-USA
HUA, Lan, 2747 De Medio CourtApt 103B, Mountain View, California 94040, US-USA MORGAN, Bradley, 120 Rimer Drive, Moraga, California 94556, US-USA
(74) Agent or Attorney Zacco Norway AS, Postboks 2003 Vika, 0125 OSLO, Norge
(54) Title SUBSTITUTED BENZALDEHYDE COMPOUNDS AND METHODS FOR THEIR USE IN INCREASING TISSUE OXYGENATION
(56) References
Cited: WO-A2-2007/061923, OSHEIZA ABDULMALIK ET AL: "Crystallographic analysis of human hemoglobin elucidates the structural basis of the potent and dual antisickling activity of pyridyl derivatives of vanillin", ACTA CRYSTALLOGRAPHICA SECTION D BIOLOGICAL CRYSTALLOGRAPHY, vol.125, no.11, 1 November 2011 (2011-11-01), pages 788-928, XP055203573, ISSN: 0907-4449, DOI: 10.1107/S0907444911036353, US-A1- 2001046997, US-A1- 2005085484, US-A1- 2010204235, SINGH V ET AL: "Reductive-Cyclization-Mediated Synthesis of Fused Polycyclic Quinolines from Baylis -Hillman Adducts of Acrylonitrile: Scope and Limitations", EUROPEAN JOURNAL OF ORGANIC CHEMISTRY, WILEY - V C H VERLAG GMBH & CO. KGAA, DE, no.20, 1 July 2009 (2009-07-01), pages 3454-3466, XP002576761, ISSN: 1434-193X, DOI: 10.1002/EJOC.200900336 [retrieved on 2009-05-28], NNAMANI I N ET AL: "Pyridyl derivatives of benzaldehyde as potential antisickling agents", CHEMISTRY & BIODIVERSITY, HELVETICA CHIMICA ACTA, ZUERICH, CH, vol.5, no.9, 1 September 2008 (2008-09-01), pages 1762-1769, XP002732217, ISSN: 1612-1872, DOI: 10.1002/CBDV.200890165 [retrieved on 2008-09-24], EP-A1- 0268989, EP-A1- 0528337, EP-A1- 0637586, WO-A1-93/17013, WO-A1-2004/014899, WO-A1-2005/047249, US-A- 5679 678, ROLAN P E ET AL: "The pharmacokinetics, tolerability and pharmacodynamics of tucaresol (589C80); 4[2-formyl-3-hydroxyphenoxymethyl] benzoic acid), a potential anti-sickling agent, following oral administration to healthy subjects", BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, BLACKWELL SCIENTIFIC PUBL, GB, vol.35, no.4, 1 April 1993 (1993-04-01), pages 419-425, XP002000120, ISSN: 0306-5251, STARKE I ET AL: "Quinoxalines. Part 13: Synthesis and mass spectrometric study of aryloxymethylquinoxalines and benzo[b]furylquinoxalines", TETRAHEDRON, ELSEVIER SCIENCE PUBLISHERS, AMSTERDAM, NL, vol.60, no.29, 12 July 2004 (2004-07-12) , pages 6063-6078, XP004517638, ISSN: 0040-4020, DOI: 10.1016/J.TET.2004.05.064, BEENA ET AL: "Synthesis and antibacterial activity evaluation of metronidazole-triazole conjugates", BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, PERGAMON, AMSTERDAM, NL, vol.19, no.5, 1 March 2009 (2009-03-01), pages 1396-1398, XP025994279, ISSN: 0960-894X, DOI:
10.1016/J.BMCL.2009.01.037 [retrieved on 2009-01-19], WO-A2-2009/050183
Enclosed is a translation of the patent claims in Norwegian. Please note that as per the Norwegian Patents Acts, section 66i the patent will receive protection in Norway only as far as there is agreement between the translation and the language of the application/patent granted at the EPO. In matters concerning the validity of the patent, language of the application/patent granted at the EPO will be used as the basis for the decision. The patent documents published by the EPO are available through Espacenet (http://worldwide.espacenet.com) or via the search engine on our website here: https://search.patentstyret.no/
Krav
Avsender
Org.nummer: 982702887
Statushistorie for 2022/11163
Hovedstatus | Beslutningsdato, detaljstatus |
---|---|
Avgjort | Forespørsel tatt til følge |
Under behandling | Mottatt |
Fullmektig i Norge:
Org.nummer: 982702887
- Org.nummer:
- Foretaksnavn:
- Foretaksform:
- Næring:
-
Forretningsadresse:
Fullmektig i EP:
2011.12.28, US 201161581053 P
2012.06.18, US 201261661320 P
BEENA ET AL: "Synthesis and antibacterial activity evaluation of metronidazole-triazole conjugates", BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, PERGAMON, AMSTERDAM, NL, vol. 19, no. 5, 1 March 2009 (2009-03-01), pages 1396-1398, XP025994279, ISSN: 0960-894X, DOI: 10.1016/J.BMCL.2009.01.037 [retrieved on 2009-01-19] (B1)
WO-A2-2009/050183 (B1)
EP-A1- 0 528 337 (B1)
EP-A1- 0 637 586 (B1)
NNAMANI I N ET AL: "Pyridyl derivatives of benzaldehyde as potential antisickling agents", CHEMISTRY & BIODIVERSITY, HELVETICA CHIMICA ACTA, ZUERICH, CH, vol. 5, no. 9, 1 September 2008 (2008-09-01), pages 1762-1769, XP002732217, ISSN: 1612-1872, DOI: 10.1002/CBDV.200890165 [retrieved on 2008-09-24] (B1)
OSHEIZA ABDULMALIK ET AL: "Crystallographic analysis of human hemoglobin elucidates the structural basis of the potent and dual antisickling activity of pyridyl derivatives of vanillin", ACTA CRYSTALLOGRAPHICA SECTION D BIOLOGICAL CRYSTALLOGRAPHY, vol. 125, no. 11, 1 November 2011 (2011-11-01), pages 788-928, XP055203573, ISSN: 0907-4449, DOI: 10.1107/S0907444911036353 (B1)
ROLAN P E ET AL: "The pharmacokinetics, tolerability and pharmacodynamics of tucaresol (589C80); 4[2-formyl-3-hydroxyphenoxymethyl] benzoic acid), a potential anti-sickling agent, following oral administration to healthy subjects", BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, BLACKWELL SCIENTIFIC PUBL, GB, vol. 35, no. 4, 1 April 1993 (1993-04-01), pages 419-425, XP002000120, ISSN: 0306-5251 (B1)
SINGH V ET AL: "Reductive-Cyclization-Mediated Synthesis of Fused Polycyclic Quinolines from Baylis-Hillman Adducts of Acrylonitrile: Scope and Limitations", EUROPEAN JOURNAL OF ORGANIC CHEMISTRY, WILEY - V C H VERLAG GMBH & CO. KGAA, DE, no. 20, 1 July 2009 (2009-07-01), pages 3454-3466, XP002576761, ISSN: 1434-193X, DOI: 10.1002/EJOC.200900336 [retrieved on 2009-05-28] (B1)
STARKE I ET AL: "Quinoxalines. Part 13: Synthesis and mass spectrometric study of aryloxymethylquinoxalines and benzo[b]furylquinoxalines", TETRAHEDRON, ELSEVIER SCIENCE PUBLISHERS, AMSTERDAM, NL, vol. 60, no. 29, 12 July 2004 (2004-07-12) , pages 6063-6078, XP004517638, ISSN: 0040-4020, DOI: 10.1016/J.TET.2004.05.064 (B1)
US-A- 5 679 678 (B1)
US-A1- 2001 046 997 (B1)
US-A1- 2005 085 484 (B1)
US-A1- 2010 204 235 (B1)
WO-A1-2004/014899 (B1)
WO-A1-2005/047249 (B1)
WO-A1-93/17013 (B1)
WO-A2-2007/061923 (B1)
EP-A1- 0 268 989 (B1)
Statushistorie
Hovedstatus | Beslutningsdato, detaljstatus |
---|---|
EP patent gjort gjeldende i Norge | EP patent besluttet gjeldende i Norge |
EP under behandling | Forespørsel om å gjøre EP patent gyldig er mottatt |
Korrespondanse
Dato
Type korrespondanse
Journal beskrivelse
|
---|
Innkommende
EP Publiseringsdokument fra EPO
|
Innkommende
EP Publiseringsdokument fra EPO
|
Innkommende
EP Publiseringsdokument fra EPO
|
Utgående
EP Registreringsbrev (3210)
|
Innkommende
Søknadsskjema Patent
|
Innkommende
EP Publiseringsdokument fra EPO
|
Til betaling:
Neste fornyelse/årsavgift:
Betalingshistorikk:
Beskrivelse / Fakturanummer | Betalingsdato | Beløp | Betaler | Status |
---|---|---|---|---|
Årsavgift 13. avg. år (EP) | 2024.11.25 | 5460 | MASTER DATA CENTER INC | Betalt og godkjent |
Årsavgift 12. avg. år (EP) | 2023.11.28 | 3850 | MASTER DATA CENTER INC | Betalt og godkjent |
Årsavgift 11. avg. år (EP) | 2022.12.08 | 3500 | CPA GLOBAL LIMITED | Betalt og godkjent |
Årsavgift 10. avg. år (EP) | 2021.12.09 | 3200 | CPA GLOBAL LIMITED | Betalt og godkjent |
Årsavgift 9. avg. år (EP) | 2020.12.09 | 2850 | CPA GLOBAL LIMITED | Betalt og godkjent |
Årsavgift 8. avg. år (EP) | 2019.12.10 | 2550 | CPA GLOBAL LIMITED | Betalt og godkjent |
Årsavgift 7. avg. år (EP) | 2018.12.11 | 2200 | CPA GLOBAL LIMITED | Betalt og godkjent |
31717659 expand_more expand_less | 2017.11.09 | 5500 | Zacco Norway AS | Betalt |
Valideringsgebyr EP-patent
5500 = 1 X 5500
|
||||
Årsavgift 6. avg. år (EP) | 2017.10.16 | 2000 | ZACCO NORWAY AS | Betalt og godkjent |